Kidney Transplant

last authored: March 2009, David LaPierre
last reviewed:

 

 

Introduction

any type of renal failure

highly sensitized

HLA matched

 

Reasons Against Kidney Transplants

The age cutoff is..

co-morbidities which are relative contra-indications include cardiovascular disease.

Kidneys come from live-related donors, from brain-dead donors, or from those recently deceased.

return to top

 

 

 

Procedure

Panel Reactive Antibody is a blood test used to screen for anti-HLA antibodies in preparation for kidney transplant.

The score, measured from 0-99%, represents the chance of acute rejection.

It is measured using a panel of T and B lymphocytes.

Donated kidneys are usually implanted in the right or left iliac fossa. The renal artery is sutured to the external or internal iliac artery, and the renal vein to the external iliac vein. The ureter is implanted in the bladder wall.

return to top

 

 

 

Preventing and Treating Kidney Rejection

Reactivation of latent infections/colonization

 

Cellular-mediated rejection, involving CD4 and CD8 lymphocytes, is resolvable in 95% of cases.

The immune system attacks transplants. To avoid immediate rejection, host and donor kidneys need to have compatible blood types.

Human leukocyte antigens (HLAs) are highly polymorphic. Mismatch, particularly in HLA-A, HLA-B, or HLA-DR, increases risk of rejection.

Immunosuppression inhibits immune responses and reduces chance rejection, but does increase risk of infection or tumour. Important medications include corticosteroids, cyclosporin, azathioprine, mycophenolate, tacrolimus, rapamycin, or other medications.

return to top

 

 

 

Other Complications of Transplantation

 

Early Complications

Early complications can be numerous and hard to distinguish etiologically. Poor renal function can indicate acute rejection, cyclosporin toxicity, or acute tubular necrosis due to ischemia. Biopsy can be helpful in distinguishing cause.

Cellular rejection is cell-mediated and is treated with medications (see below) or antibody therapy. Vascular rejection is more aggressive and is often antibody mediated.

Cytomegalovirus (CMV) infection can cause fever, retinopathy, hepatitis, enteritis, pneumonitis, or thrombopenia.

Post-transplant lymphoproliferative disease is a lymphoma-like condition caused by Epstein-Barr virus. It can go into remission if immunosuppressants are removed.

 

Chronic Complications

Loss of renal function, or chronic rejection, is due to both immune- and non-immune mechanisms. Cyclosporin nephrotoxicity, hypertension, and recurrent disease (especially focal sclerosing glomerulosclerosis, mebranoproliferative nephropathy, and IgA nephropathy) can all contribute.

Hypertension can result from steroid use, cyclosporin-induced vascocontriction, renin secretion, or renal artery stenosis.

Hyperlipidemia is common with steroid or cyclosporin therapy.

Osteoporosis can follow steroid use.

Elevated parathyroid hormone (PTH) levels can cause phosphaturia, requiring phosphate supplements, and sometimes hypercalcemia.

Skin cancer is a late complication (why?)

return to top

 

 

 

Resources and References

return to top